Streetbeat News

Earnings

BMR

ORCL

RNA

Market-Moving News for June 12th includes Beamr's cloud solution availability in Oracle Cloud Marketplace, Avidity's positive trial results for a muscular dystrophy treatment, and Oracle's partnership with Microsoft and OpenAI despite a Q4 miss.

Portfolio Pulse from ryanfaloona@benzinga.com

June 12, 2024 | 12:50 pm

DLX

FAST

Insiders have made notable purchases in Zillow Group, Fastenal, and Deluxe Corporation, indicating confidence in these companies. Zillow's Director acquired $99.97 million worth of shares following upbeat quarterly results. Fastenal's Director bought shares despite poor Q1 results. Deluxe's CEO purchased shares after better-than-expected earnings.

Portfolio Pulse from Avi Kapoor

June 12, 2024 | 12:45 pm

GOOG

MSFT

ORCL

Oracle Corp (NYSE:ORCL) shares are trading higher following the company's quarterly results and announcements of partnerships with Google, Microsoft, and OpenAI. Despite missing revenue and earnings estimates, Oracle highlighted strong AI demand and record-level sales contracts. Multiple analysts raised their price targets for Oracle.

Portfolio Pulse from Adam Eckert

June 12, 2024 | 12:44 pm

NTR

Nutrien is set to present its strategic priorities and 2026 targets at its Investor Day. The company aims for a Retail adjusted EBITDA of $1.9B-$2.1B in 2026, with a goal of $1.4B in gross margin from proprietary products. Nutrien plans to reduce controllable costs by $200M and maintain annual capital expenditures of $2.2B-$2.3B through 2026.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 12:44 pm

ABM

AMSC

SRCL

VRSK

Four industrial stocks, American Superconductor Corporation (AMSC), Verisk Analytics (VRSK), Stericycle Inc (SRCL), and ABM Industries Inc (ABM), are currently overbought according to their RSI values, indicating potential short-term price declines. Despite recent strong financial results and stock gains, these stocks may face downward pressure.

Portfolio Pulse from Avi Kapoor

June 12, 2024 | 12:41 pm

JAGX

Jaguar Health, Inc. (NASDAQ:JAGX) will present results from its Phase 3 OnTarget trial for the cancer supportive care drug Crofelemer by July 23, 2024. The webcast will include updates on Jaguar's cancer supportive care portfolio and feature insights from the scientific team, patient advocates, and oncology experts.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 12:38 pm

RNA

Avidity shares are trading higher following the announcement of positive initial data from the Phase 1/2 FORTITUDE trial for AOC 1020, showing significant reductions in DUX4 regulated genes and trends of functional improvement in patients with facioscapulohumeral muscular dystrophy.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 12:30 pm

KFY

Top Wall Street analysts have updated their expectations for Korn Ferry (NYSE:KFY) ahead of its Q4 earnings release. Analysts predict earnings of $1.12 per share and revenue of $689.92 million. Recent analyst ratings include UBS with a Neutral rating and a price target of $68, Baird with an Outperform rating and a price target of $72, and Truist Securities with a Buy rating.

Portfolio Pulse from Avi Kapoor

June 12, 2024 | 12:23 pm

ASTS

FER

GME

MAMA

NIO

SAGE

TBPH

UBXG

Several big stocks, including Mama's Creations, GameStop, and others, are moving lower in Wednesday's pre-market session. Mama's Creations reported downbeat earnings, while other companies like U-BX Technology, Ferrovial, and Theravance Biopharma also saw declines.

Portfolio Pulse from Avi Kapoor

June 12, 2024 | 12:18 pm

CASY

EATZ

PSL

Casey's General Stores (NASDAQ:CASY) shares are surging premarket after reporting strong Q4 and FY24 results, with sales and EPS exceeding expectations. The company also announced a 16% dividend increase and plans for significant store expansion in FY25.

Portfolio Pulse from Lekha Gupta

June 12, 2024 | 12:17 pm